Analyst Ratings for Baxter International (BAX)
BAX Rating Summary
BAX Price Target Summary
- Highest: $79.00 (Bernstein)
- Lowest: $57.00 (Citi)
- Average: $67.20
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$67.20 (-8%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/7/2013 | Barclays | Upgrade | Overweight (Equalweight) |
N/A (N/A) |
70.31 | 73.04 | 3.88% | Details |
| 11/27/2012 | Mizuho Securities | Downgrade | Neutral (Outperform) |
72.00 (72.00) |
66.84 | 73.04 | 9.28% | Details |
| 11/20/2012 | Stifel Nicolaus | New Coverage | Hold (N/A) |
N/A (N/A) |
66.49 | 73.04 | 9.85% | Details |
| 11/14/2012 | Bernstein | New Coverage | Outperform (N/A) |
79.00 (N/A) |
65.95 | 73.04 | 10.75% | Details |
| 10/4/2012 | Cowen | New Coverage | Outperform (N/A) |
N/A (N/A) |
61.17 | 73.04 | 19.4% | Details |
| 9/24/2012 | Deutsche Bank » Updated 4/12/2013 |
Downgrade | Hold (Buy) |
75.00 (71.00) |
61.01 | 73.04 | 19.72% | Details |
| 9/19/2012 | BMO Capital | New Coverage | Outperform (N/A) |
70.00 (N/A) |
60.96 | 73.04 | 19.82% | Details |
| 7/19/2012 | Standpoint Research | Downgrade | Hold (Buy) |
N/A (N/A) |
56.17 | 73.04 | 30.03% | Details |
| 6/19/2012 | Goldman Sachs » Updated 7/25/2012 |
Upgrade | Conviction Buy (Buy) |
67.00 (64.00) |
49.92 | 73.04 | 46.31% | Details |
| 4/25/2012 | Raymond James | New Coverage | Outperform (N/A) |
N/A (N/A) |
54.76 | 73.04 | 33.38% | Details |
| 2/24/2012 | Citi | Upgrade | Neutral (N/A) |
57.00 (N/A) |
56.59 | 73.04 | 29.07% | Details |
| 12/20/2011 | RBC Capital | Downgrade | Outperform (N/A) |
58.00 (N/A) |
47.65 | 73.04 | 53.28% | Details |
| 10/5/2011 | Credit Agricole | New Coverage | Outperform (N/A) |
66.00 (N/A) |
54.00 | 73.04 | 35.26% | Details |
| 9/27/2011 | JPMorgan | Upgrade | Overweight (N/A) |
64.00 (N/A) |
54.33 | 73.04 | 34.44% | Details |
| 6/15/2011 | Brean Capital | New Coverage | Buy (N/A) |
N/A (N/A) |
58.69 | 58.08 | -1.04% | Details |
